For the Inventor, By the Inventor

Enter assignee name

Tokyo Tanabe Company, Ltd.

USPTO Granted Patents = 41

CIPO Patents = 1

Forward Citations = 269

Loading Chart...

Loading Chart...

85 inventors (with patents filed for the assignee):

Kiyokazu Murakami (5 out of 5 patents)

Akio Okamura (4 out of 4 patents)

Shinzo Nakazawa (4 out of 4 patents)

4. Naoto Matsuishi (4 out of 4 patents)

5. Shinji Tsuchiya (3 out of 6 patents)

6. Takashi Yazaki (3 out of 3 patents)

7. Susumu Yokura (3 out of 3 patents)

8. Hiromi Kimura (3 out of 3 patents)

9. Shoichi Moro (3 out of 3 patents)

10. Shigeki Omura (3 out of 3 patents)

11. Tsunetomo Takei (3 out of 3 patents)

12. Toshio Kawashima (3 out of 3 patents)

13. Nobuyuki Yasuda (2 out of 32 patents)

14. Shuri Yamada (2 out of 9 patents)

15. Goro Kimura (2 out of 4 patents)

Core Competencies:

Bile Acid Converting Microorganism

Indoline Compounds

Respiratory-Tract Viral Disease

Cholestasis Ameliorant

Hepatitis C Virus Inhibitor

Inflammatory Intestinal Diseases

Bifidobacterium Growth Promoter

Pyrido[1,2-a]Pyrimidine Compounds

Antiulcer Agents

Surfactant Compositions

Hydrophobic Polypeptide Purification

D-Ribose Production

41 patents: Sort by Forward Citations

1. 5989855 - Bile acid converting microorganism and process for preparing bile acid (1999-11-23),

2. 5936098 - Process for producing indoline compounds and intermediates for the (1999-08-10),

3. 5900401 - Remedy for respiratory-tract viral disease (1999-05-04),

4. 5869319 - Bile acid-converting microorganism Bacillus sp. and a method of use (1999-02-09),

5. 5863550 - Cholestasis ameliorant (1999-01-26),

6. 5849801 - 4-amino-5-oxy-2,6,6-trimethyl-2-cycloheptene compounds (1998-12-15),

7. 5846964 - Hepatitis C virus proliferation inhibitor (1998-12-08),

8. 5840741 - Arteriosclerosis depressant (1998-11-24),

9. 5827825 - Synthetic peptide, lung surfactant containing the same and remedy for (1998-10-27),

10. 5798120 - Enteric granule-containing tablets (1998-08-25),

11. 5720439 - High speed agitated granulation method and high speed agitated (1998-02-24),

12. 5677326 - Indoline compound and 5-HT.sub.3 receptor antagonist containing the same (1997-10-14),

13. 5661166 - Saishin N compounds, process for preparing same and antiulcer agents (1997-08-26),

14. 5648457 - Purification method for hydrophobic polypeptide (1997-07-15),

15. 5601873 - Method for granulating and coating (1997-02-11),

Tokyo Tanabe Company, Ltd. is a Japanese pharmaceutical company based in Tokyo. Established in 1678, it has a long history in the healthcare industry, specializing in the research, development, manufacture, and sale of pharmaceutical products. Tokyo Tanabe is committed to contributing to society through innovative medicines that help improve the health and well-being of people worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

41 Patents

#794 in Tokyo

#1,898 in Japan

#16,214 in the World

Tokyo Tanabe Company, Ltd.

Forward Citations = 269

85 inventors:

Kiyokazu Murakami (5 out of 5 patents)

Akio Okamura (4 out of 4 patents)

Shinzo Nakazawa (4 out of 4 patents)

4. Naoto Matsuishi (4 out of 4 patents)

5. Shinji Tsuchiya (3 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…